| Nov 13 |
Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up
|
| Nov 13 |
Q3 2024 Axsome Therapeutics Inc Earnings Call
|
| Nov 12 |
Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Axsome Therapeutics, Inc. (AXSM) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Axsome Therapeutics Q3 Earnings: Stay For The Near Term Catalysts, Then Sell
|
| Nov 12 |
Axsome Hits 52-Week High After Surging Nearly 5%--FDA Milestones Could Fuel Even Bigger Gains
|
| Nov 12 |
Axsome Therapeutics, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 12 |
Axsome Therapeutics GAAP EPS of -$1.34 beats by $0.07, revenue of $104.76M beats by $6.69M
|
| Nov 12 |
Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
